Acne keloidalis is a type of chronic condition due to inflammation of hair follicle. Acne keloidalis usually occurs as an itchy bump at the back of the head or nape of the neck.
Acne keloidalis is a type of chronic condition due to inflammation of hair follicle. Acne keloidalis usually occurs as an itchy bump at the back of the head or nape of the neck. Acne keloidalis can happen due to close shaving, chronic infections, and allergy from certain medications or genetic mutations. Acne keloidalis can develop from surgery, piercing, vaccination, burn injury, or trauma. Acne keloidalis is more common in dark-skinned people than white ones.
It is diagnosed by the emergence of papules, scars and pustules on the occipital area of the scalp. Acne keloidalis treatment options include medication, laser therapy or surgery depending upon the severity of the condition. According to the British Skin Foundation, acne keloidalis is common among African men with a prevalence rate of 0.45-9%
Emergence of coronavirus has led to the focus of various leading biopharmaceuticals towards developing COVID 19 cure impacting acne keloidalis treatment market. There was a reduction in manufacturing activities due to lockdown implemented in several countries harming acne keloidalis treatment market. There was an observed decline in hospital visits and treatment adoption rate having significant impact restraining acne keloidalis treatment market growth.
Get Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6992
Acne Keloidalis Treatment Market: Drivers and Restraints
Increasing prevalence of skin disorders is expected to rise in demand for acne keloidalis treatment market during the forecast period. The rise in the number of surgical procedures also boosts the demand for acne keloidalis treatment market. Whereas, increasing awareness about the treatment options available for keloidalis will propel acne keloidalis treatment market growth. Aesthetic consciousness among the general population is the major driving factor for acne keloidalis treatment market growth. The number of burn injury cases is also expected to increase demand for acne keloidalis treatment market in the coming decade. Antibiotics can lead to skin irritation and résistance, and challenge acne keloidalis treatment market growth. Surgical removal and laser therapy for acne keloidalis will challenge acne keloidalis treatment market growth market growth.
Acne Keloidalis Treatment Market: Segmentation
Based on drug type, acne keloidalis treatment market is segmented into the following:
- Anti-inflammatory Biologics
- Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
- Corticosteroids
Based on the prescription type, the global acne keloidalis treatment market is segmented as:
- Physician prescribed
- Over-the-counter
Based on the dosage form, the global acne keloidalis treatment market is segmented as:
- Spray
- Cream
- Gel
- Ointment
- Elastic wraps
Based on the route of administration, the global acne keloidalis treatment market is segmented as:
- Oral
- Topical
- Injectable
Based on the distribution channel, the global acne keloidalis treatment market is segmented as:
- Hospital pharmacies
- Retail pharmacies
- Drug stores
- Online pharmacies
Acne Keloidalis Treatment Market: Overview
Corticosteroids is the most common drug type in acne keloidalis treatment market. Over-the-counter type of drugs contributes the majority of revenue for acne keloidalis treatment market. Whereas, based on dosage form cream and gel hold a majority of revenue share in acne keloidalis treatment market. The topical route of administration is most common in acne keloidalis treatment market followed by the oral route of administration. Retail pharmacies is the leading distribution channel in acne keloidalis treatment market with majority sale of over-the-counter medicine. Online pharmacies will observe significant growth rate in the coming decade with increased adoption of e-commerce in acne keloidalis treatment market.
Acne Keloidalis Treatment Market: Region-wise Outlook
North America is expected to dominate the acne keloidalis treatment market during the forecast period with a large focus on research and development activities and product innovation in the region. Europe tends to be the second leading region in acne keloidalis treatment market with a higher concern of aesthetics and awareness about treatment options among the general population.
Get Table of Content of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=6992
Latin America will observe moderate growth in acne keloidalis treatment market in the coming decade. On the other hand, Asia Pacific is estimated to observe an exponential rise in acne keloidalis treatment market with an increasing number of domestic players in countries like India, China and Japan. The Middle East and Africa will less healthcare expenditure rate is less lucrative for acne keloidalis treatment market growth.
Acne Keloidalis Treatment Market: Key Market Participants
Major players in Acne Keloidalis Treatment Market are Bristol-Myers Squibb Company, Valeant Pharmaceuticals International, Inc., Smith & Nephew Plc., Renovo Group Plc., CCA Industries, Merz, Inc., Galena Biopharma, Inc., Scarheal, Inc., Cynosure, Inc., SNaltus LLC, NewMedical Technology, Inc., Suneva Medical, Inc., Sonoma Pharmaceuticals, Inc., Lumenis, Molnlycke Healthcare and others.
The research report on acne keloidalis treatment market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report on acne keloidalis treatment market provides analysis and information according to market segments such as prescription type, dosage form, route of administration, distribution channel and region.
About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.
Contact:
Rohit Bhisey
TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Visit Site: https://www.tmrresearch.com/